Your browser doesn't support javascript.
loading
Psychological Support for Personality (PSP) versus treatment as usual: study protocol for a feasibility randomized controlled trial of a low intensity intervention for people with personality disorder.
Crawford, Mike J; Thana, Lavanya; Parker, Jennie; Turner, Oliver; Xing, Kwek Pei; McMurran, Mary; Moran, Paul; Weaver, Timothy; Barrett, Barbara; Claringbold, Amy; Bassett, Paul; Sanatinia, Rahil.
Afiliación
  • Crawford MJ; Personality Disorder Research Unit, Centre for Psychiatry, Imperial College London, London, UK. m.crawford@imperial.ac.uk.
  • Thana L; Department of Medicine, Division of Brain Sciences, Centre for Psychiatry, 7th Floor Commonwealth Building, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK. m.crawford@imperial.ac.uk.
  • Parker J; Personality Disorder Research Unit, Centre for Psychiatry, Imperial College London, London, UK.
  • Turner O; Department of Medicine, Division of Brain Sciences, Centre for Psychiatry, 7th Floor Commonwealth Building, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Xing KP; Research and Development Department, Central and North West London NHS Foundation Trust, Stephenson House, 75 Hampstead Road, London, NW1 2PL, UK.
  • McMurran M; Barnet, Enfield and Haringey NHS Foundation Trust, St Ann's Hospital, St Ann's Road, Haringey, London, N15 3TH, UK.
  • Moran P; Personality Disorder Research Unit, Centre for Psychiatry, Imperial College London, London, UK.
  • Weaver T; Department of Medicine, Division of Brain Sciences, Centre for Psychiatry, 7th Floor Commonwealth Building, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Barrett B; Section of Forensic Mental Health, University of Nottingham, Nottingham, NG7 2UH, UK.
  • Claringbold A; School of Social and Community Medicine, Bristol University, Oakfield House, Oakfield Grove, Bristol, BS8 2BN, UK.
  • Bassett P; Mental Health Social Work & Integrative Medicine, Middlesex University, The Burroughs, Hendon, London, NW4 4BT, UK.
  • Sanatinia R; Centre for the Economics of Mental and Physical Health, King's College London, David Goldberg Centre, De Crespigny Park, London, SE5 8AF, UK.
Trials ; 19(1): 547, 2018 Oct 10.
Article en En | MEDLINE | ID: mdl-30305148
ABSTRACT

BACKGROUND:

Previous research has demonstrated the clinical effectiveness of long-term psychological treatment for people with some types of personality disorder. However, the high intensity and cost of these interventions limit their availability. Lower-intensity interventions are increasingly being offered to people with personality disorder, but their clinical and cost effectiveness have not been properly tested in experimental studies. We therefore set out to develop a low intensity intervention for people with personality disorder and to test the feasibility of conducting a randomized controlled trial to compare the clinical effectiveness of this intervention with that of treatment as usual (TAU).

METHODS:

A two-arm, parallel-group, single-blind, randomized controlled trial of Psychological Support for Personality (PSP) versus TAU for people aged over 18 years, who are using secondary care mental health services and have personality disorder. We will exclude people with co-existing organic or psychotic mental disorders (dementia, bipolar affective disorder, delusional disorder, schizophrenia, schizoaffective disorder, or schizotypal disorder), those with cognitive or language difficulties that would preclude them from providing informed consent or compromise participation in study procedures, and those who are already receiving psychological treatment for personality disorder. Participants will be randomized via a remote system in a ratio of PSP to TAU of 11. Randomization will be stratified according to the referring team and gender of the participant. A single follow-up assessment will be conducted by masked researchers 24 weeks after randomization to assess mental health (using the Warwick and Edinburgh Well-Being Schedule), social functioning (using the Work and Social Adjustment Scale), health-related quality of life (EQ-5D-5 L), incidence of suicidal behavior, satisfaction with care (Client Satisfaction Questionnaire), and resource use and costs using a modified version of the Adult Service Use Schedule. In addition to this, each participant will be asked to complete the patient version of the Clinical Global Impression Scale. Feasibility and acceptability will primarily be judged by study recruitment rate and engagement and retention in treatment. The analysis will focus principally on descriptive data on the rate of recruitment, characteristics of participants, attrition, adherence to therapy, and follow-up. We will explore the distribution of study outcomes to investigate assumptions of normality in order to plan the analysis and sample size of a future definitive trial.

DISCUSSION:

Most people with personality disorder do not currently receive evidence-based interventions. While a number of high intensity psychological treatments have been shown to be effective, there is an urgent need to develop effective low intensity approaches to help people unable to use existing treatments. PSP is a low intensity intervention for individuals, which was developed following extensive consultation with users and providers of services for people with personality disorder. This study aims to examine the feasibility of a randomized trial of PSP compared to TAU for people with personality disorder. TRIAL REGISTRATION ISRCTN Registry, ISRCTN14994755 . Registered on 18 July 2017.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Personalidad / Trastornos de la Personalidad / Psicoterapia / Sistemas de Apoyo Psicosocial Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Personalidad / Trastornos de la Personalidad / Psicoterapia / Sistemas de Apoyo Psicosocial Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Año: 2018 Tipo del documento: Article